We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$220M
AUM Growth
+$21.9M
Cap. Flow
+$60M
Cap. Flow %
27.25%
Top 10 Hldgs %
29.91%
Holding
89
New
19
Increased
34
Reduced
13
Closed
20

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$3.92M
2
ISRG icon
Intuitive Surgical
ISRG
+$3.35M
3
SYK icon
Stryker
SYK
+$3.29M
4
RMD icon
ResMed
RMD
+$2.29M
5
UHS icon
Universal Health Services
UHS
+$2.12M

Sector Composition

Rank Sector Weight
1 Healthcare 89.08%
2 Energy 0.53%
3 Industrials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
26
DELISTED
Allergan Inc
AGN
$3.56M 1.62%
20,000
-5,000
-20% -$830K
ISRG icon
27
Intuitive Surgical
ISRG
$141B
$3.46M 1.57%
+67,500
New +$3.35M
HSP
28
DELISTED
HOSPIRA INC
HSP
$3.38M 1.54%
65,000
+17,603
+37% +$935K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$134B
$3.37M 1.53%
30,000
+10,000
+50% +$952K
TRNX
30
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$3.35M 1.52%
140,000
+15,000
+12% +$335K
CELG
31
DELISTED
Celgene Corp
CELG
$3.32M 1.51%
35,000
+20,000
+133% +$1.8M
ACH
32
Accendra Health
ACH
$93.4M
$3.27M 1.49%
100,000
+33,100
+49% +$1.13M
SYK icon
33
Stryker
SYK
$133B
$3.23M 1.47%
+40,000
New +$3.29M
AMN icon
34
AMN Healthcare
AMN
$1.31B
$3.14M 1.43%
200,000
+58,894
+42% +$839K
ENDP
35
DELISTED
Endo International plc
ENDP
$3.08M 1.4%
45,000
+14,200
+46% +$935K
SCAI
36
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$3.07M 1.4%
114,869
+47,662
+71% +$1.39M
TEVA icon
37
Teva Pharmaceuticals
TEVA
$42.5B
$2.96M 1.34%
55,000
HRC
38
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.9M 1.32%
70,000
+27,192
+64% +$1.14M
TMH
39
DELISTED
Team Health Holdings Inc
TMH
$2.9M 1.32%
50,000
-10,000
-17% -$558K
MOH icon
40
Molina Healthcare
MOH
$10.2B
$2.75M 1.25%
65,000
-31,921
-33% -$1.41M
ICLR icon
41
Icon
ICLR
$12.7B
$2.58M 1.17%
45,000
-15,000
-25% -$772K
MDVN
42
DELISTED
MEDIVATION, INC.
MDVN
$2.47M 1.12%
+50,000
New +$2.12M
HNT
43
DELISTED
HEALTH NET INC
HNT
$2.44M 1.11%
52,800
+2,800
+6% +$124K
WCG
44
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.41M 1.1%
40,000
+5,000
+14% +$332K
UAM
45
DELISTED
Universal American Corp
UAM
$2.41M 1.1%
300,000
-25,000
-8% -$207K
ELV icon
46
Elevance Health
ELV
$84.5B
$2.39M 1.09%
20,000
-25,000
-56% -$2.87M
CCRN
47
DELISTED
Cross Country Healthcare
CCRN
$2.32M 1.06%
250,000
+50,000
+25% +$383K
ABBV icon
48
AbbVie
ABBV
$438B
$2.31M 1.05%
40,000
-45,000
-53% -$2.5M
A icon
49
Agilent Technologies
A
$42.3B
$2.28M 1.04%
55,920
+13,980
+33% +$571K
RMD icon
50
ResMed
RMD
$32.1B
$2.22M 1.01%
+45,000
New +$2.29M

Similar funds

Sivik Global Healthcare's Q3 2014 Portfolio in Review

As of Q3 2014, Sivik Global Healthcare held 89 positions worth $220M, up 11% from $198M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Sivik Global Healthcare deployed $60M of net new capital in Q3 2014, opening 19 new positions and adding to 34 existing holdings. Its largest new stake was Amgen: 30,000 shares worth $4.21M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Elevance Health, an estimated $2.87M trimmed.

  • Sivik Global Healthcare's largest Q3 2014 buy was Amgen: 30,000 shares worth $4.21M.
  • Sivik Global Healthcare added most to Universal Health Services in Q3 2014, an estimated $2.12M increase.
  • Sivik Global Healthcare's biggest Q3 2014 reduction was Elevance Health, cutting an estimated $2.87M.
  • Sivik Global Healthcare fully exited Shire pic in Q3 2014, selling an estimated $4.71M.
  • Sivik Global Healthcare's ten largest holdings make up 30% of its $220M portfolio in Q3 2014.
  • Sivik Global Healthcare opened 19 new positions and closed 20 in Q3 2014.
  • Sivik Global Healthcare's portfolio value rose 11% quarter-over-quarter to $220M.

Based on Sivik Global Healthcare's 13F filing for Q3 2014, filed 3 Oct 2014.